These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6540424)

  • 21. [Psammoma bodies in the cervico-vaginal smear. Association with bilateral ovarian carcinoma].
    Meniconi R; Izzi M
    Pathologica; 1982; 74(1033):691-5. PubMed ID: 7167280
    [No Abstract]   [Full Text] [Related]  

  • 22. Preoperative serum CA125 in surgical stage 1 epithelial ovarian cancer.
    Obermair A
    Gynecol Oncol; 2007 Nov; 107(2):357-8. PubMed ID: 17706272
    [No Abstract]   [Full Text] [Related]  

  • 23. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.
    Han LY; Landen CN; Kamat AA; Lopez A; Bender DP; Mueller P; Schmandt R; Gershenson DM; Sood AK
    J Clin Oncol; 2006 Feb; 24(5):755-61. PubMed ID: 16380413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A rational selection of retroperitoneal lymphadenectomy for advanced epithelial ovarian cancer].
    Wang W; Sun R; Ma L
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):108-9. PubMed ID: 11263195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Super radical surgery of advanced ovarian cancers (stages III and IV)].
    Michel G; Castaigne D; Morice P; Lhommé C; Duviliard P
    Contracept Fertil Sex; 1997 Jun; 25(6):V-XI. PubMed ID: 9280543
    [No Abstract]   [Full Text] [Related]  

  • 28. Intraoperative consultation in ovarian lesions: a comparison between cytology and frozen section.
    Michael CW; Lawrence WD; Bedrossian CW
    Diagn Cytopathol; 1996 Dec; 15(5):387-94. PubMed ID: 8989540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surgery of primary cancers of the ovary].
    Bobin JY
    Rev Prat; 1997 Jun; 47(11):1199-203. PubMed ID: 9238815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term results of organ preserving therapy in ovarian carcinoma].
    Meier W; Korell M; Burges A; Hepp H
    Zentralbl Gynakol; 1996; 118(10):545-8. PubMed ID: 8999706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neoplasms of the genitalia in young girls].
    Kutusheva GF
    Vestn Khir Im I I Grek; 2000; 159(1):41-5. PubMed ID: 10890098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
    Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
    Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary adenocarcinoma of the ovary presenting in a PAP-smear.
    Huijssoon A; Sastrowijoto P; Harmsel BT
    Acta Obstet Gynecol Scand; 2001 Jul; 80(7):659-60. PubMed ID: 11437726
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytologic presentation of ovarian adenosquamous carcinoma in ascitic fluid. A case report.
    Tsukamoto N; Matsukuma K; Daimaru Y; Ota M
    Acta Cytol; 1984; 28(6):703-5. PubMed ID: 6594883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
    Schröder W
    Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
    Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
    Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
    Wingo SN; Knowles LM; Carrick KS; Miller DS; Schorge JO
    Am J Obstet Gynecol; 2006 May; 194(5):e20-2. PubMed ID: 16647891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of psammoma bodies in cervical cytology.
    Joseph P; Rana DN; Marshall J; Desai M
    Cytopathology; 2006 Dec; 17(6):399-401. PubMed ID: 17168925
    [No Abstract]   [Full Text] [Related]  

  • 40. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.